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Abstract
Heterogeneous aggregates of the human protein a-synuclein (aSyn) are abundantly found in Lewy body
inclusions of Parkinson’s disease patients. While structural information on classical aSyn amyloid fibrils is
available, little is known about the conformational properties of disease-relevant, non-canonical aggre-
gates. Here, we analyze the structural and dynamic properties of megadalton-sized dityrosine adducts
of aSyn that form in the presence of reactive oxygen species and cytochrome c, a proapoptotic peroxidase
that is released from mitochondria during sustained oxidative stress. In contrast to canonical cross-b amy-
loids, these aggregates retain high degrees of internal dynamics, which enables their characterization by
solution-state NMR spectroscopy. We find that intermolecular dityrosine crosslinks restrict aSyn motions
only locally whereas large segments of concatenated molecules remain flexible and disordered. Indistin-
guishable aggregates form in crowded in vitro solutions and in complex environments of mammalian cell
lysates, where relative amounts of free reactive oxygen species, rather than cytochrome c, are rate lim-
iting. We further establish that dityrosine adducts inhibit classical amyloid formation by maintaining aSyn
in its monomeric form and that they are non-cytotoxic despite retaining basic membrane-binding proper-
ties. Our results suggest that oxidative aSyn aggregation scavenges cytochrome c’s activity into the for-
mation of amorphous, high molecular-weight structures that may contribute to the structural diversity of
Lewy body deposits.
 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecom-
mons.org/licenses/by/4.0/).Introduction
Lewy body (LB) aggregates of the pre-synaptic
protein aSyn are pathological hallmarks of
Parkinson’s disease1,2 and related synucle-
inopathies.3 Whereas ageing and cellular oxidative
stress are common denominators in synucle-or(s). Published by Elsevier Ltd.This is an opinopathies, LB morphologies and aSyn aggregate/-
fibril structures differ in a source-of-origin and
disease-specific manner,4–7 suggesting that aggre-
gation pathways, fibril strains and aggregate com-
positions are likely influenced by context-
dependent factors that are altogether poorly under-
stood.8 Similarly, the toxicity and spreading of aSynen access article under the CC BY license (http://creativecommons.org/
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regions and cell types,4 which underscores the
confounding compositional, functional and struc-
tural heterogeneity of aSyn aggregates in these
disorders.5
Mitochondria emerged as key organelles in
mediating possible aggregation scenarios of
aSyn,9 especially in relation to reactive oxygen
species (ROS) production, oxidative stress sens-
ing, and as executioners of programmed cell death,
i.e. apoptosis.10 Recent findings substantiate this
notion by revealing direct interactions between
aSyn and mitochondrial membranes and lipids,11,12
aSyn-induced organelle toxicity,4,13,14 stress-
related re-localization of aSyn to mitochondria15,16
and pathological co-localization with mitochondria
(and other non-proteinaceous structures) in brain-
derived LB inclusions17 and cellular models of LB
formation and maturation.4 In addition, the func-
tions of many other Parkinson’s disease proteins
converge on mitochondria and are directly linked
to mitochondrial biology.18
Cytochrome c (cyt c) resides in the inner
mitochondrial membrane (IMM) where it is bound
to cardiolipin, an organelle-specific, negatively-
charged phospholipid.19 Under physiological cell
conditions, cyt c transfers electrons between com-
plex III and IV of the electron transport chain and
oxidizes superoxide anions to molecular oxygen
(O2) as a ROS scavenger. Upon cumulating oxida-
tive stress, cardiolipin oxidation frees cyt c from the
IMM and the protein is actively released into the
cytoplasm where it acts as an apoptotic messen-
ger.20 Cytoplasmic cyt c ultimately induces cas-
pase activation and cell death, although
mitochondrial outer membrane permeation
(MOMP) and cyt c release do not strictly trigger
apoptosis and several non-deleterious functions
have been discovered recently.20 Amongst them,
cyt c acts as a peroxidase and oxidizes proteins
and lipids in the presence of ROS.21 In substrates
such as aSyn, cyt c-mediated oxidation primarily
targets exposed tyrosine residues and leads to
the formation of dityrosine crosslinks that locally
concatenate individual molecules into covalent,
high molecular weight aggregates.22,23
aSyn is a 140-residue protein that contains four
tyrosines. One in its N-terminal part (Y39) and
three at its C-terminus (Y125, Y133 and Y136).
aSyn dityrosine adducts are found in Lewy body
deposits of Parkinson’s disease (PD) patients and
in neuronal inclusions of PD mouse models23,24
that also stain positive for cyt c.25,26 Cyt c-
mediated dityrosine aggregation of aSyn has
been reconstituted with isolated components
in vitro,26–32 however, no attempts have been made
to study the structures of the resulting species at
the atomic-resolution level. Here, we delineate the
structural and dynamic properties of aSyn dity-
rosine aggregates by solution-state nuclear mag-2
netic resonance (NMR) spectroscopy and
complementary methods including dynamic light
scattering (DLS), circular dichroism (CD), atomic
force (AFM) and negative-stain transmission elec-
tron microscopy (TEM), and mass spectrometry
(MS). We show that despite their exceedingly large
size, they retain individually crosslinked aSyn mole-
cules in highly dynamic disordered conformations
that resemble the biophysical properties of the
monomeric protein. Importantly, we establish that
residues of the amyloidogenic NAC region of aSyn
are minimally perturbed in these assemblies and
display no signs of b-aggregation, regardless of
their close proximity and high local concentrations.
We further demonstrate that cyt c-mediated aSyn
aggregates form in macromolecularly crowded, cel-
lular environments, where they exhibit structural
and dynamic characteristics that are indistinguish-
able from aggregates reconstituted with purified
components in vitro.Results
aSyn dityrosine crosslinking produces high
molecular weight aggregates
To obtain structural insights into aSyn dityrosine
adducts, we reconstituted peroxidase reactions
with equal amounts of recombinant, N-terminally
acetylated aSyn (50 lM) and purified cyt c to
which we added 50, 100, or 500 lM of hydrogen
peroxide (H2O2). We resolved the resulting
mixtures by denaturing sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE)
and visualized proteins by Coomassie staining
(Figure 1(a)–(c)). In line with previous
reports,22,26,27 we detected multiple low molecular
weight aggregates (LMWAs) at limiting H2O2 con-
centrations, whereas high molecular weight aggre-
gates (HMWAs) formed in the presence of excess
peroxide (Figure 1(a)). Although we did not observe
protein precipitation in any of these reaction mix-
tures, soluble HMWAs were retained in the loading
slots and stack portions of SDS gels. At high H2O2
concentrations, aSyn was quantitatively incorpo-
rated into HMWAs, whereas input levels of mono-
meric cyt c were largely preserved, as expected
for an enzymatic reaction and in agreement with
published data.27 To evaluate the minimal stoichio-
metric requirements for cyt c in these reactions, we
reconstituted oxidative aSyn aggregation with
reduced amounts of peroxidase (Figure 1(b)). At
aSyn (50 lM) to cyt c molar ratios of 100:1 and
50:1, LMWAs formed readily. At a 10:1 ratio of
aSyn to cyt c, most of aSyn was incorporated into
HMWAs. These results confirmed that aggregation
of aSyn into covalent adducts in the presence of
H2O2 only required catalytic amounts cyt c. Next,
we asked whether LMWAs constituted reaction
intermediates en route to HMWA formation. We
added increasing amounts of cyt c to preformed
Figure 1. Biochemical and biophysical characterization of aSyn dityrosine aggregates. (a) Coomassie-stained
SDS-PAGE of low and high molecular weight aggregates of aSyn (50 lM) with 50 lM cyt c and 0, 50, 100 or 500 lM
H2O2. (b) Aggregation of aSyn (50 lM) with 0.1, 1 or 5 lM cyt c and 10 mM H2O2. (c) Preformed low molecular weight
aggregates (50 lM aSyn, 1 lM cyt c, 10 mM H2O2, marked with an asterisk) reacted with 2, 10 or 50 lM cyt c. All
reactions were allowed to proceed for 30 min at 25 C. Loading slots and gel stacks are indicated with arrowheads. (d)
Atomic force microscopy (AFM, top) and negative stain transmission electron microscopy (TEM, bottom) of purified
high molecular weight aggregates (HMWAs) of aSyn. Control amyloid fibrils are shown on the right. (e) Biophysical
characterization of monomeric aSyn (50 lM, black) and purified HMWAs (50 lM, red) by CD spectroscopy, DLS, SEC
and fluorescence emission spectroscopy. (f) Coomassie-stained SDS-PAGE of aSyn low and high molecular weight
aggregates (LMWAs and HMWAs, left) and corresponding Western blot (WB) analyses, with antibodies against N-
and C-terminal aSyn epitopes, cyt c and dityrosine adducts. Dotted horizontal lines connect WB signals to
corresponding Coomassie protein bands. Loading slots and gel stacks are indicated with arrowheads.
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(Figure 1(c)). Having resolved the respective mix-
tures by SDS-PAGE, we found that LMWAs effi-
ciently converted into HMWAs and that final
HMWA abundance correlated with cyt c input con-
centrations. Aiming to further characterize the
structural details of cyt c/H2O2-mediated aSyn
aggregates, we purified HMWAs and
analyzed them by AFM and negative-stain TEM
(Figure 1(d)). Both methods revealed amorphous
globular structures of 30–50 nm diameters (10–
15 nm heights), with different macroscopic features
compared to canonical amyloid fibrils. Solution
characterization by CD spectroscopy, DLS, size-
exclusion chromatography (SEC) and ultraviolet
(UV) absorption measurements showed that
HMWAs retained high degrees of structural disor-
der and uniform DLS distributions centered at
~30 nm, roughly the diameter of assembled eukary-
otic ribosomes,33 compared to ~6 nm for mono-
meric aSyn (Figure 1(e)). HMWAs eluted as
single peaks in SEC void volumes, separated from
non-incorporated cyt c and well set off from mono-
meric aSyn, and displayed fluorescence emission
bands at 404 nm, which are characteristic for dity-
rosine adducts.34 To determine the molecular com-
positions of aSyn aggregates, we probed LMWAs
and HMWAs with different aSyn, cyt c and
dityrosine-specific antibodies by Western blotting
(Figure 1(f)). Antibodies against N-terminal (aa6-
23), or C-terminal (aa120-125) aSyn epitopes rec-
ognized dimer-, trimer- and higher oligomeric-
species in LMWAs that corresponded in size to
Coomassie-stained protein bands, confirming that
these adducts contained aSyn. The dityrosine anti-
body reacted with the same set of bands, validating
the presence of intermolecular crosslinks. It
showed no signal for monomeric aSyn, which sug-
gested that intramolecular dityrosines did not form
to a significant extent. By contrast, the cyt c anti-
body recognized different sets of low molecular
weight bands that corresponded to monomeric cyt
c and to cyt c oligomers with no corresponding
Coomassie bands. These adducts contained no
aSyn based on Western blotting results, which
established that aSyn-aSyn dityrosine adducts con-
stituted the primary species in LMWAs. Antibodies
against C-terminal portions of aSyn, where Y125,
Y133 and Y136 are located, and against dityrosi-
nes failed to recognize their epitopes in HMWAs,
which suggested that crosslinking rendered these
sites inaccessible for antibody binding. Antibodies
against the N-terminus of aSyn and against cyt c
produced HMWA signals, indicating that N-
terminal aSyn residues remained accessible and
that some co-aggregated cyt c was present. These
results confirmed that intermolecular dityrosine
crosslinks between individual aSyn molecules
formed the basis of low and high molecular weight
aggregates.4
Dityrosine aggregates are disordered and
dynamic
To derive high-resolution insights into the
structural and dynamic properties of aSyn in
HMWAs, we reconstituted aggregates with 15N
isotope-labeled, N-terminally acetylated aSyn and
unlabeled cyt c in the presence of peroxide. We
removed H2O2 and free cyt c by SEC and pooled
HMWA fractions for solution-state NMR
experiments. Despite the exceedingly large size
of these assemblies, usually beyond the scope of
solution NMR measurements, 2D 1H-15N
heteronuclear correlation spectra of HMWAs were
of excellent quality and revealed the majority of
aSyn signals at resonance positions
corresponding to those of the monomeric protein
(Figure 2(a)). These NMR characteristics
substantiated CD results about the disordered
nature of aSyn in these aggregates (Figure 1(e))
and established that crosslinked aSyn molecules
retained high degrees of internal dynamics. Upon
closer inspection of NMR spectra, we noted
pronounced chemical shift changes for N-terminal
aSyn residues 1–10, including M1 and M5, that
we and others had previously identified as
characteristic for oxidized methionines (i.e.
methionine sulfoxides),35,36 confirming that NMR
samples had indeed formed under oxidative condi-
tions. Importantly, we also noted continuous
stretches of severely line-broadened NMR signals
for residues around Y39, Y125, Y133 and Y136,
the four tyrosines of aSyn and possible sites of dity-
rosine crosslinks. To verify that detected NMR sig-
nals indeed originated from aSyn aggregates, we
performed diffusion ordered spectroscopy (DOSY)
measurements on HMWAs (Figure 2(b)). DOSY
results indicated that HMWA diffusion was greatly
reduced compared to monomeric aSyn and corre-
sponded to a megadalton-sized ~35 nm diameter
particle, in good agreement with TEM and DLS
results (Figure 1(d) and (e)).
To further explore aSyn dynamics in HMWAs, we
analyzed signal intensity attenuations on a residue-
resolved basis and performed longitudinal (R1) and
transverse (R2) relaxation experiments as well as
heteronuclear Overhauser effect (hetNOE)
measurements (Figure 2(c)). We determined
intensity ratios (I/I0) for well-resolved HMWA
signals (I) in relation to monomeric aSyn (I0) and
found that site-selective line broadening centered
at Y39 and C-terminal Y125, Y133 and Y136. In
relation to these sites, attenuations weakened in
a distance-dependent manner, with more
expansive effects around Y39 compared to Y125,
Y133 and Y136 (Figure 2(c), top). aSyn residues
comprising the aggregation-prone non-amyloid
component (NAC) region (aa60-95) displayed
minimal line-broadening, which suggested that
their overall structural and dynamic properties
were retained in HMWAs. N-terminal aSyn
Figure 2. Structural and dynamic characterization of HMWAs. (a) Overlay of 2D 1H-15N NMR spectra of 15N
isotope-labeled, N-terminally acetylated, monomeric aSyn (50 lM, black) and of HMWAs (50 lM, red). HMWA
resonances broadened beyond detection are labeled. Chemical shift changes of N-terminal aSyn residues 1–10 are
shown in blue. NMR signals Y39, Y125, Y133 and Y136 are highlighted in grey. (b) DOSY- measurements of
monomeric aSyn (black) and HMWAs (red). (c) top: Residue-resolved analysis of NMR signal intensity ratios (I/I0)
between HMWAs (I) and monomeric aSyn (I0). Blue bars correspond to N-terminal aSyn residues 1–10. Black bars
denote I/I0 values of well-resolved HMWA resonances. middle: Overlay of backbone amide R1 (1/T1, top) and R2 (1/
T2, bottom) relaxation rates of monomeric aSyn (black) and HMWAs (red). bottom: het NOE values of monomeric
aSyn (black) and HMWAs (red). Light grey boxes indicate resonances not included in the analysis due to signal
overlap. The central NAC region is shown in dark grey. N- and C-terminal tyrosines are highlighted. (d) Coomassie-
stained SDS-PAGE of aSyn HMWAs (50 lM) generated by PICUP. Loading slots and gel stacks are indicated by
arrows. Summary of dityrosine crosslinks identified in PICUP HMWAs by MS. (e) Selected region of 2D 1H-15N NMR
spectra of 15N isotope-labeled, N-terminally acetylated, monomeric aSyn (50 lM, black) and of PICUP-HMWAs
(50 lM, red). HMWA resonances broadened beyond detection are labeled, NMR signals of Y39, Y125, Y133 and
Y136 are highlighted in grey. All NMR spectra were recorded at 283 K (10 C).
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broadening effects, indicating equally preserved
dynamics in HMWAs and probably explaining the
observed antibody accessibility (Figure 1(f)).
Quantitative R1 and R2 results supported these
conclusions by establishing that fast picosecond
to nanosecond amide backbone motions (R1)
were marginally affected, whereas R2 profiles
showed position-dependent attenuations
consistent with restricted motions and/or
conformational exchange on the microsecond to
millisecond timescale (Figure 2(c), middle).
hetNOE data confirmed that HMWAs displayed
independent segmental motions characteristic for
a disordered protein (Figure 2(c), bottom). The
qualitative picture that emerged from these
experiments stipulated that dityrosine crosslinks
restricted backbone motions of concatenated
aSyn molecules only in the vicinity of crosslinked
residues, whereas remote sites retained high
degrees of flexibility and conformational
dynamics. On the macroscopic level, these
results supported a model of loosely packed,
macromolecular assemblies of disordered
molecules held together by repeating,
intermolecular side-chain crosslinks.
To independently verify the general nature of
these dityrosine aggregate characteristics, we
resorted to photoinduced crosslinking of
unmodified proteins (PICUP) and reacted
N-terminally acetylated aSyn with ammonium-
persulfate (APS) and Ruthenium (Ru3+) under
light as reported previously.28 PICUP HMWAs
displayed similar SDS-PAGE migration properties
as cyt c/H2O2-mediated aggregates in that aSyn
was quantitatively converted into high molecular
weight species retained in loading slots and stack-
ing gels (Figure 2(d)). Exploiting the homogenous
nature of PICUP HMWAs, we analyzed aggre-
gates by MS to delineate dityrosine positions and
relative distributions (Figure S1(a)). We identified
crosslinks of Y39 peptides to aSyn fragments
containing Y39, Y125, Y133 and Y136. Similarly,
we detected intermolecular Y133-Y133 and Y136-
136 crosslinks, but no intra- or inter-molecular
adducts between other C-terminal tyrosines (Fig-
ures 2(d) and S1(a)). These results supported the
central role of Y39 as a connectivity hub in aSyn
PICUP aggregates, in line with previous findings.28
To compare the structural features of PICUP
HMWAs and cyt c/H2O2-mediated assemblies, we
recorded NMR spectra on photo-induced aggre-
gates of 15N isotope-labeled aSyn (Figures 2(e)
and S1(b)). Surprisingly, both types of HMWAs
displayed virtually indistinguishable spectral fea-
tures, especially in terms of site-selective line
broadening. Different to cyt c/H2O2 HMWAs,
however, we did not observe N-terminal aSyn resi-
dues 1–10 in NMR spectra of PICUP aggregates.
Our combined NMR data established that dity-
rosine HMWAs of aSyn exhibited similar structural6
and dynamic properties irrespective of whether
they were generated via a protein-catalyzed perox-
idase reaction or directly by photo-induced
crosslinking.Dityrosine aggregates form in complex
environments
Next, we asked whether cyt c/H2O2 HMWAs of
aSyn formed in the presence of competing
interactions with other macromolecules in
crowded environments. We initially employed
bovine serum albumin (BSA), which has been
shown to transiently interact with N-terminal aSyn
residues and to bind to Y39 via weak hydrophobic
contacts,16,37 and reconstituted cyt c/H2O2 aggre-
gation reactions with 15N isotope-labeled aSyn
and increasing amounts of unlabeled BSA (Figure 3
(a)). SDS-PAGE analysis revealed that stacking
gel-retained HMWAs specifically formed in solu-
tions of up to 10 mg/mL of BSA, which was the
highest concentration we used to avoid overloading
the gel. We reacted 15N isotope-labeled aSyn with
unlabeled cyt c and H2O2 in the presence of a 20-
fold higher amount of BSA (200 mg/mL) and
recorded in situ NMR experiments on the resulting
mixture (Figures 3(b) and S2(a)). Similar to previ-
ous results, we obtained high quality NMR spectra
that revealed the characteristic line-broadening
profile of dityrosine-crosslinked aSyn, which con-
firmed that cyt c/H2O2 aggregation of aSyn
occurred under highly crowded in vitro conditions
and regardless of protein–protein interactions that
involved Y39. Following these observations, we
extended our analysis to neuronal RCSN3 cell
lysates.38 We adjusted total lysate protein concen-
trations to 3 mg/mL and added equimolar amounts
of aSyn and cyt c (50 lM) and 0.5–500 mM of
H2O2. Western blotting revealed that aggregate for-
mation only occurred at the highest peroxide con-
centration (Figure 3(c), top), in contrast to
previous experiments with isolated components
(Figure 1) and in BSA-crowded solutions (Figure 3
(a)). We hypothesized that peroxide-metabolizing
enzymes may have cleared exogenously added
H2O2. Indeed, when we measured remaining
H2O2 levels using a colorimetric assay, we found
that only 1.8 ± 0.8% of input peroxide (10 mM)
was present in these lysates (Figure 3(c)). To
weaken endogenous peroxidase activities, we trea-
ted RCSN3 lysates with diethyl pyrocarbonate
(DEPC), a chemical that inactivates enzymes by
irreversible carbethoxylation of active site
residues.39 Because DEPC has a limited lifetime
in aqueous solutions and decomposes readily,
one of its advantages over enzyme inactivation by
acid, SDS, or high temperature denaturation is
the preservation of otherwise native lysate condi-
tions. Accordingly, we adjusted the timing of lysate
inactivation by DEPC (Figure S2(b)) and added
- DEPC
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Figure 3. HMWA formation in crowded environments. (a) Coomassie-stained SDS-PAGE of aSyn (50 lM)
aggregation reactions with cyt c (50 lM) and H2O2 (10 mM) in the presence of 5 or 10 mg/mL of BSA. Loading slots
and gel stacks are indicated by arrows. (b) Selected region of 2D 1H-15N NMR spectra of 15N isotope-labeled, N-
terminally acetylated, monomeric aSyn (50 lM) in the presence of 200 mg/mL BSA (black). Note that N-terminal aSyn
residues 1–10 in the reference spectrum are broadened beyond detection due to transient interactions with BSA. Y39
signal intensity of monomeric aSyn is attenuated for the same reason. The corresponding in situ NMR spectrum of
HMWAs (50 lM) formed in the presence of BSA is overlaid in red. Broadened HMWA resonances are labeled, NMR
signals of Y39, Y125, Y133 and Y136 are highlighted in grey. (c) HMWA formation in RCSN3 cell lysates (total protein
concentration 3 mg/mL). top: Western blotting of aggregation reactions in native RCSN3 lysates upon addition of
aSyn (50 lM), cyt c (50 lM) and 0.5 – 500 mM H2O2. Colorimetric quantification of remaining peroxide levels after
addition of 10 mM H2O2. bottom: Western blotting of aggregation reactions in DEPC-inactivated RCSN3 lysates upon
addition of aSyn (50 lM), cyt c (50 lM) and 0.5 – 500 mM H2O2, with remaining peroxide levels after addition of
10 mM H2O2 shown on the right. (d) Selected region of 2D
1H-15N NMR spectra of 15N isotope-labeled, N-terminally
acetylated, monomeric aSyn (50 lM) in DEPC-treated RCSN3 lysate (black) and in situ NMR spectrum of HMWAs
(50 lM) formed after addition of cyt c (50 lM) and 50 mM H2O2 (red). HMWA resonances broadened beyond
detection are labeled. Chemical shift changes of N-terminal aSyn residues 1–10 are shown in blue. NMR signals Y39,
Y125, Y133 and Y136 are highlighted in grey. All NMR spectra were recorded at 283 K (10 C).
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(c), bottom). Under these conditions, 40 ± 0.5%
of exogenously added peroxide was preserved
and we detected aSyn aggregation at correspond-
ingly lower H2O2 concentrations. We repeated
these reactions with 15N isotope-labeled aSyn
and recorded in situ NMR experiments in DEPC-
treated RCSN3 lysates (Figures 3(d) and S2(c)).
2D NMR spectra exhibited compelling degrees of
similarity with other HMWA samples. We clearly
observed the spectral fingerprints of dityrosine
crosslinks manifested by the conserved line-
broadening of residues neighboring Y39, Y125,
Y133 and Y136, and the characteristic chemical
shift changes of N-terminal aSyn residues due to
methionine oxidation (see Figure 2(a) for compar-
ison). Together with results in BSA-crowded solu-
tions, these findings demonstrated that cyt c/
H2O2-mediated aggregates of aSyn formed effi-
ciently in complex physiological environments,
especially under conditions of sustained ROS avail-
ability required for dityrosine crosslinking.
Dityrosine aggregates bind membranes, inhibit
amyloid formation and are non-cytotoxic
Because N-terminal aSyn residues that mediate
lipid-anchoring contacts40 remained accessible in
HMWAs, we asked whether aggregates retained
the ability to interact with membranes. We added
15N isotope-labeled monomeric and HMWA aSyn
to small unilamellar vesicles (SUVs) that we recon-
stituted from pig-brain polar lipid extract. In line with
previous results on such SUVs,37 monomeric aSyn
displayed continuous line-broadening of residues
1–100, which serves as a widely used indicator
for aSyn membrane binding41,42 (Figures 4(a) and
S3(a)). Surprisingly, 2D NMR spectra of 15N
isotope-labeled HMWAs exhibited equally pro-
nounced line-broadening in the presence of SUVs
(Figure 4(b) and S3(b)). By contrast, however,
remaining HMWA resonances included stretches
of residues within the first 100 amino acids of aSyn,
spanning V70 to Q79 for example, which collec-
tively suggested that HMWA-SUV contacts were
different than those of the monomeric protein.
Given that aSyn interacts with membranes in heli-
cal conformations,43 we asked whether HMWAs
adopted similar helical structures and recorded
CD spectra of monomeric and HMWA aSyn in the
presence of SDS micelles, a common surrogate
for studying Syn’s a-helical conversion upon mem-
brane binding44 (Figure 4(c)). We found that mono-
meric and HMWA aSyn displayed helical
signatures in corresponding CD spectra, which
suggested that HMWA-membrane interactions trig-
gered some degrees of a-helical rearrangements.
Finally, we sought to revisit HMWA effects on the
aggregation behavior(s) of monomeric aSyn. Previ-
ous studies suggested that dityrosine adducts of
aSyn impaired the formation of cross-b amyloid
structures in a concentration-dependent manner.318
In agreement with these findings, we observed the
quantitative inhibition of thioflavin T (ThT)-positive
aggregate formation in shaking assays when we
added 10% HMWAs to monomeric aSyn (Figure 4
(d)). To investigate the mode of inhibition, we
repeated these assays with 15N isotope-labeled,
monomeric aSyn and unlabeled HMWAs, and
measured 1D 15N-edited NMR spectra at different
time-points of the reaction. In the absence of
HMWAs, we observed the progressive attenuation
of NMR signals as expected for the incorporation of
monomeric aSyn into growing amyloid fibrils (Fig-
ure 4(e)). In the presence of HMWAs, NMR signal
intensities of aSyn did not diminish substantially,
suggesting that inhibition was mediated by the
preservation of the monomeric protein state and
not by the generation of ThT-negative, off-
pathway aggregates as has been observed for
many other inhibitors.45 To assess whether
HMWAs were cytotoxic, we measured the meta-
bolic activity of PC12 cells to which we added
protofibrils generated from monomeric aSyn, puri-
fied HMWAs and aliquots of inhibited aggregation
mixtures containing aSyn and HMWAs that we col-
lected after 22 and 48 hours (Figure 4(f)). Addition
of protofibrils decreased the conversion of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbro
mide (MTT) into formazan in a concentration-
dependent manner, in line with previous reports
of cell metabolic activity46 and characteristic of
cytotoxic aggregates.47 By contrast, neither purified
HMWAs nor aSyn-HMWAs mixtures impaired cell
viability and specimens displayed no signs of cellu-
lar stress (Figure 4(f)). These results established
that exogenously added dityrosine aggregates of
aSyn inflicted no adverse effects on the metabolic
activity and viability of PC12 cells.Discussion
Recent years saw a wealth of high-resolution
structural information about aSyn oligomers48 and
amyloid fibrils,49 ranging from in vitro reconstituted
assemblies to specimens directly derived from
post-mortem brains.50 Correlative imaging studies
delivered complementary insights into the composi-
tions and morphologies of Lewy bodies and their
complex nature in terms ofmembrane and organelle
inclusions, and the abundance of heterogeneous
aggregate structures.4,5,17 Parallel to these
advancements, functional links between ageing,
cellular oxidative stress, neurodegeneration and
oxidative aSyn modifications have been explored
for some time.51 In this context, our results add pri-
mary insights into the structure and dynamics of
non-canonical aSyn aggregates characterized by
covalent dityrosine crosslinks between N- (Y39)
and C-terminal (Y125, Y133, Y136) residues. We
demonstrate that these aggregates efficiently form
under oxidative conditions in the presence of cat-
alytic amounts of a peroxidase enzyme (cytochrome
Figure 4. HMWA membrane-binding, aggregation inhibition and cellular toxicity. (a) Selected region of 2D 1H-15N
NMR spectra of 15N isotope-labeled, N-terminally acetylated, monomeric aSyn (50 lM, black) and in the presence
of -SUVs (red). Non-broadened NMR signals of C-terminal aSyn residues are labeled. Y125, Y133 and Y136 are
highlighted in grey. (b) Same selected region of 15N isotope-labeled HMWAs (50 lM, black) and upon binding to SUVs
(red). NMR spectra were recorded at 303 K (30 C). Non-broadened NMR signals are labeled. (c) top: Overlay of CD
spectra of monomeric aSyn (50 lM, black) and in the presence of SDS micelles (red). bottom: Overlay of CD spectra
of purified HMWAs (50 lM, black) and in the presence of SDS micelles (red). (d) Kinetic b-aggregation assays and
measured ThT fluorescence emission for monomeric, 15N isotope-labeled aSyn (50 lM, black) and in the presence of
10% unlabeled HMWAs (green). NMR samples were collected at 22 and 48 h timepoints for respective 1D NMR
measurements. (e) 1D 15N-edited NMR signals of monomeric aSyn in aggregation reactions without (grey to black)
and with 10% HMWAs (green). (f) Metabolic MTT assays on PC12 cells upon addition of aSyn protofibrils (black),
purified HMWAs (red) and aliquots of inhibited aggregation reactions after 22 h (light green) and 48 h (dark green), at
the indicated concentrations. Bar graphs denote changes in metabolic activity expressed in % compared to untreated
cells. Phase-contrast microscopy images of PC12 cells incubated with 1 lM of aSyn protofibrils or 1 lM of HMWAs
are shown on the right. All error bars depict SEM values from triplicate measurements.
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locally concatenated assemblies that retain high
degrees of structural disorder and internal dynamics
(Figure 2(a)–(c)). Although we intentionally chose
‘exhaustive’ reaction conditions to produce
homogenous endpoint products (i.e. HMWAs), we
reason that the structural and dynamic properties
that we elucidated are similarly displayed in mix-
tures of lower molecular-weight aggregates (i.e.
LMWAs), which constitute reaction intermediates
(Figure 1(c)). Having established that aSyn dity-
rosine aggregates also form in artificially crowded
in vitro solutions and cell lysates (Figure 3) further
strengthens the notion that crosslinking avidity and
specificity are well preserved in complex physiolog-
ical environments and that these aggregates may
co-exist with monomeric, oligomeric or fibrillar forms
of aSyn in cells. Furthermore, it seems plausible that
mixed dityrosine adducts between different aSyn
species can form, especially under conditions of
sustained oxidative stress and considering the per-
sistent reactivity of unmodified tyrosine residues.
Such mixed crosslinks may modify non-covalent
aSyn aggregates or stabilize existing aSyn fib-
rils.22,52 In this regard, it is interesting to note that
Y39, Y125, Y133 and Y136 in structures of reconsti-
tuted aSyn fibrils are not part of the ordered amyloid
cores and do not contribute to protofilament pack-
ing,49 which suggests that theymay remain accessi-
ble for oxidative crosslinking. Indeed, results from
dityrosine-aSynEM immunogold co-labeling studies
on PD patient-derived Lewy bodies confirm the
presence of such species in physiological sam-
ples.24 Co-aggregation with non-covalent aSyn fib-
rils may further explain certain aspects of
morphological changes during Lewy body matura-
tion, especially at later stages when fibrillar struc-
tures convert into extended spherical inclusions.4
Intriguingly, this transition coincides with the recruit-
ment of mitochondria into Lewy bodies,4 which are
abundantly found in mature deposits.17 This puts
aSyn, mitochondrial cytochrome c and the sites of
ROS production in close proximity and it is straight-
forward to imagine how these encounters may drive
or perpetuate the formation of dityrosine aggre-
gates, as well as impede cellular functions such as
proteasomal degradation, chaperone-mediated
autophagy,53 or illicit inflammatory activation of
neighboring cells upon excretion.54 In this regard,
results pertaining to the non-cytoxicity of HMWAs
when externally applied to PC12 cells ought to be
considered with caution (Figure 4(f)). Because stan-
dard MTT assays do not provide information about
aggregate internalization, we are unable to assess
whether they cross the plasma membrane and
reach the cytoplasm to cause intracellular effects.
Alternatively, monomeric or oligomeric aSyn may
directly engage with mitochondria and actively con-
tribute to ROS production, cytochrome c release
and, in turn, dityrosine aggregate formation.55 It is
important to stress, however, that the generation10of aSyn dityrosine adducts does not strictly require
a peroxidase enzyme (i.e. cytochrome c) and that
they can form as reaction side-products of tyrosine
nitration, by dopamine-mediated autoxidation, or in
the presence of oxidized lipids or divalent metals.51
Thus, cellular scenarios in which such aggregates
are generated with or without the involvement of
mitochondria are manifold.
Dityrosine crosslinks may further render involved
residues inert to other post-translational
modifications (PTMs) such as nitration56 and phos-
phorylation.57 All aSyn tyrosines undergo reversible
phosphorylation58 and PTM cross-talk between
Y125 and S129 phosphorylation, as well as M127
oxidation is well established.36,59 Crosslinks are
likely to impair the accessibility of these sites and,
thereby, modulate the enzymatic establishment or
removal of individual PTMs. With regard to aSyn
S129 phosphorylation, the pathological hallmark
of Lewy body inclusions,60 they may help to
preserve this modification by restricting access of
bulky phosphatase holoenzymes.61 Intriguingly,
mitochondrial recruitment and phospho-S129
accumulation coincide with Lewy body maturation.4
Similarly, dityrosine adducts and aberrant PTM
states may diminish aSyn interactions with other
proteins, including the endocytosis GTPase
Rab862 and the synaptic vesicle v-SNARE
component synaptobrevin-2/VAMP2,63 which may
exert debilitating effects on the physiological
functions of aSyn, probably exacerbated by the
residual membrane-binding activity of these
adducts (Figure 4(b)). They may further affect C-
terminal proteolytic processing events64 and the
cellular clearance of aSyn.51 Given that covalent
dityrosine crosslinks represent irreversible protein
modifications that cannot be undone by cellular
enzymes, their impact on aSyn’s biology is
persistent.
In summary, our results established that
oxidative aggregation of aSyn via dityrosine
crosslinking imposes minor effects on N-terminal
and central portions of the protein, with residues
involved in membrane anchoring and of the
amyloidogenic NAC region being largely
unperturbed (Figure 2). The resulting degrees of
conformational freedom appear to allow for
structural rearrangements required for helical
membrane-binding (Figure 4(b) and (c)) and to
mediate the inhibition of NAC-dependent cross-b
amyloid formation (Figure 4(d) and (e)), probably
via capping of growing fibril ends. Because three
of the four tyrosines of aSyn are located in the C-
terminus of the protein, functional consequences
are expected to be more drastic for activities
mapped to this region, including the
establishment and removal of PTMs and various
protein–protein interactions. With regard to the
involvement of cytochrome c, oxidative dityrosine
crosslinking may scavenge the activity of this
proapoptotic messenger and, in turn, delay the
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suggested earlier.26 By doing so, the outlined reac-
tion scenarios may perpetuate detrimental condi-
tions of oxidative stress and exacerbate cellular
insults that contribute to PD pathology.
Materials and Methods
Proteins
Unlabeled or uniform 15N or 15N/13C isotope-labeled, N-
terminally acetylated, human alpha-synuclein (aSyn) was
expressed and purified under native conditions as previously
described.37 Recombinant proteins were resuspended in
20 mM phosphate buffer, 150 mM NaCl at pH 6.4 (NMR buffer).
Protein concentrations were determined by UV/VIS absorption
measurements at 280 nm (k) with an extinction coefficient (e)
of 5600 M1 cm1. Purified horse heart cyt c was obtained from
Sigma, BSA was purchased from Roth. Stock solutions were
prepared in NMR buffer by weighing in the respective amounts
of protein powder and confirming absorbance at 410 nm for
cyt c (e 106.1 mM1 cm1) and at 280 nm for BSA (e
43824 M1 cm1).
Low and high molecular weight aggregates
Low molecular weight aggregates (LMWAs) of aSyn were
obtained by mixing 50 lM aSyn with 50 lM cyt c and 100 lM
hydrogen peroxide (H2O2) i.e. at a molar ratio of 1:1:2, unless
specified otherwise. High molecular weight aggregates
(HMWAs) were obtained by mixing 50 lM aSyn with 50 lM
cyt c and 2 mM H2O2 (1:1:200), unless specified otherwise.
LMWA and HMWA reactions were incubated for 30 min at
25 C to yield the respective samples. Molar aggregate
concentrations were considered equal to aSyn input
concentrations in a first approximation. For AFM and TEM
experiments and biophysical characterizations (Figure 1(d) and
(e)), NMR measurements (Figure 2(a) and (e)) and testing of
membrane binding and aggregation interference (Figure 4),
HMWAs were purified by size exclusion chromatography on a
Superdex-75 column to remove non-incorporated cyt c and
excess hydrogen peroxide (H2O2). Pooled HMWA fractions
were either used immediately or flash frozen in liquid nitrogen
and stored at 80 C. For NMR experiments, estimates of
purified 15N isotope-labeled HMWA concentrations were
derived based on 1D 15N-edited proton NMR spectra in
comparison to reference samples of monomeric aSyn at
known concentrations. Accordingly, samples were adjusted to
50 lM.
Polyacrylamide gel electrophoresis (PAGE)
Denaturing sodium dodecylsulfate (SDS) PAGE gels used in this
study were prepared on Miniprotean III systems (BioRad) with a
constant separating-gel pore size of 18% acrylamide (w/v).
Proteins were visualized by gel staining with Coomassie
Brilliant Blue (Sigma Aldrich).
Atomic force microscopy (AFM)
Sheet mica (Nanoworld) was glued to microscope glass slides
and 20 lL of 25 lM HMWAs or aSyn amyloid fibrils were
adsorbed for 10 min onto freshly cleaved mica (1  1 cm),
washed with filtered, deionized water (3  30 lL) and dried
overnight. Reference amyloid fibrils were obtained by shaking
100 lL of 50 lM aSyn in NMR buffer at 200 rpm, 37 C for
7 days. Fibrils were stored at 4 C and shortly vortexed before
experiments. Amyloid fibril concentrations were considered11equal to input amounts of aSyn. Dry AFM images were
recorded on a Nanowizard II/Zeiss Axiovert setup (JPK) using
intermittent contact mode and FEBS cantilevers (Veeco).
Negative-stain transmission electron microscopy
(TEM)
Twenty microliters of 25 lM HMWAs and aSyn amyloid fibrils
were adsorbed onto glow-discharged carbon-coated copper
grids for 1 min. Excess liquid was removed with filter paper
and grids were washed twice with H2O before staining with 2%
(w/v) uranyl acetate for 15 s. TEM images were acquired on a
Philips CM100 microscope.
Circular dichroism (CD) spectroscopy
CD measurements were performed on a Jasco J-810
spectropolarimeter at 25 C with samples at 10 lM. Far-UV
CD spectra were collected in NMR buffer using a 0.1 cm path-
length cuvette. Five scans were averaged and blank (buffer)
scans were subtracted. CD experiments with SDS-micelle
(Figure 4(c)) were performed in the same manner. Micelles
were prepared by dissolving 10 mM SDS in NMR buffer as
reported in.44
Dynamic light scattering (DLS)
DLS measurements were acquired on a Zetasizer Nano ZS
(Malvern Instruments) operating at a laser wavelength of
633 nm equipped with a Peltier temperature controller set to
25 C. Data were collected on 50 lM protein samples in NMR
buffer in 3  3 mm cuvettes. Using the Malvern DTS software,
mean hydrodynamic diameters were calculated from three
replicates in the volume-weighted mode.
Dityrosine fluorescence detection
Steady-state fluorescence detection of dityrosine crosslinks was
performed on a Jasco J-720 fluorimeter at 5 lM sample
concentrations, in 3 mm cuvettes at 25 C. Excitation was set
to 315 nm and emission spectra were recorded from 325 to
550 nm (k). The dityrosine-specific emission signal was
monitored at 410 nm according to.65
Western blotting
SDS-PAGE separated proteins were transferred onto
nitrocellulose membranes and blocked in 5% non-fat milk
dissolved in PBS supplemented with 0.01% Tween for 1 hour.
Membranes were incubated with the following monoclonal
primary antibodies at 4 C, overnight. Anti N-terminal aSyn
(Abcam, ab51252, 1:1000 dilution), C-terminal aSyn (Santa
Cruz, sc-12767, 1:200 dilution), C-terminal aSyn (Santa Cruz,
sc-69977, 1:100 dilution), full-length cyt c (Abcam, ab13575,
1:500 dilution) and dityrosine (antibodies-online, ABIN361276,
1:100 dilution). Membranes were washed and incubated with
anti-mouse or anti-rabbit secondary antibodies (1:5000
dilution) conjugated to horseradish peroxidase (HRP). Proteins
were visualized by enhanced chemiluminescence (ECL)
detection on a ChemiDoc XRS + imaging system (BioRad).
Nuclear magnetic resonance (NMR) spectroscopy
NMR experiments were performed on Bruker Avance 600 or
750 MHz spectrometers, equipped with cryogenically-cooled
triple resonance 1H{13C/15N} TCI probes and z axis self-
shielded gradient coils. Data acquisition, processing, and
S. Verzini, M. Shah, Francois-Xavier Theillet, et al. Journal of Molecular Biology 432 (2020) 166689spectral analyses were carried out in TOPSPIN 2.1, iNMR 3.6.3
and CCPNmr 2.1.5. 2D 1H-15N correlation spectra of monomeric
uniform 15N nitrogen labeled aSyn and HMWAs were acquired
using the SOFAST-HMQC pulse sequence on 50 lM samples
dissolved in NMR buffer at 10 C, with 1 K and 256 complex
points for sweep-widths (SW) of 16 ppm and 28 ppm in 1H
and 15N dimensions, respectively. Spectra were recorded with
32 scans and interscan delays of 60 ms. Processing was done
by zero-filling to 4 times the number of complex points,
followed by a sine modulated window function multiplication,
Fourier transformation (FT) and baseline correction in both
dimensions. Diffusion ordered spectroscopy (DOSY) was
performed on 50 lM monomeric aSyn and homogeneous
HMWA samples in NMR buffer. Diffusion coefficients were
obtained by fitting intensity curves from bipolar pulse-pair
longitudinal-eddy-current delay (BPPLED) experiments with an
array of linearly shifted gradient power. A series of 28 1D
NMR spectra were collected as a function of gradient
amplitude. Intensities were measured by integrating signals
from 1D proton (1H) NMR spectra between 0.75 ppm and
3.2 ppm. Monomeric aSyn and its hydrodynamic
radius/diameter (Rh) obtained by DLS was used as the
internal reference to determine Rh for HMWAs. 15N amide-
backbone relaxation data were acquired using standard pulse
sequences provided in the Bruker Topspin library. Spectra
used for longitudinal relaxation T1 (1/R1) analysis were
collected using the following delay times (in ms): 12, 52, 102,
152, 202, 302, 402, 602, 902, 2002, 5002. T2 data (1/R2) were
measured using a pulse sequence employing a CPMG pulse
train with the following delays (in ms): 6, 10, 18, 26, 34, 42,
82, 122, 162, 202, 242, 322 and 462. Duplicate spectra were
collected for several time points to estimate uncertainty. To
determine R1 and R2 relaxation rates resonance signal
intensities were extracted and fit as a function of the relaxation
delay time in CCPNmr. To obtain steady-state hetero-nuclear
(het) NOE values, we calculated ratios of peak intensities in
paired spectra collected with and without an initial 4 s period
of proton saturation during the 5 s recycling delay. For
relaxation experiments, the concentrations of aSyn and HMWA
aggregates were 50 lM. Resolution settings and processing
were the same as for 2D SOFAST-HMQC experiments. 8, 16
and 32 transients were used for T1, T2 and hetNOE
experiments, respectively. To determine residue-resolved NMR
signal intensity ratios, only cross-peaks of well-resolved aSyn
residues were used. Absolute HMWA signal intensities (I)
were divided by corresponding signals of monomeric aSyn (I0)
and I/I0 ratios were plotted against the protein sequence.
Photo-induced cross-linking of unmodified proteins
(PICUP)
PICUP HMWAs were generated by reacting 300 lM of 15N
isotope-labeled aSyn with 2 mM APS and 150 lM of tris(2,20-
bipyridyl)-dichloro-ruthenium(II)-hexahydrate, Ru(BPY)3 to
photo-oxidize Ru2+ to Ru3+ by irradiation via a fiber optic cold-
light source (Schott KL1500) for 1 minute. 300 mM
dithiothreitol (DTT) was added to stop the reaction. HMWAs
were purified by SEC on a Superdex-75 column to separate
aggregates from APS, Ru(BPY)3 and DTT, pooled and
concentrated. 50 lM aliquots of PICUP HMWAs were
analyzed by SDS-PAGE and NMR spectroscopy.
Mass spectrometry (MS)
PICUP HMWAs (20 lg) were digested (protein concentration of
0.6 mg/mL in a 20 mM HEPES, 20 mM NaCl, 5 mM MgCl2
buffer) using the endoprotease Glu-C. HMWAs were first
reduced by adding 5 mM DTT, with incubation for 30 min at
60 C, followed by alkylation with 15 mM iodoacetamide, with12incubation in the dark for 15 min at 20 C. Glu-C was then
added at a protease-to-protein ratio of 1:13 (w/w) and
digestion allowed to proceed for 18 h at 37 C. The resulting
digest was acidified to pH 2 with trifluoroacetic acid and
desalted using C18 StageTips before analysis on the mass
spectrometer. Peptides were loaded (at a flow rate of
0.5 ll min1) directly on a spray analytical column (75 lm
inner diameter, 8 lm opening, 250 mm length; New Ojectives,
Woburn, MA) packed with C18 material (ReproSil-Pur C18-AQ
3 lm) using an air pressure pump (Proxeon Biosystems). Two
gradients (at a constant flow rate of 0.3 ll min1) were used
for chromatographic separation (A: 0.1% formic acid in water,
B: 0.1% formic acid in 80/20 acetonitrile:water): Gradient 1
(increase over 95 mins) 1% B (0–24 min), 1–5% B (24–
25 min), 5–32% B (25–107 min), 32–35% B (107–114 min),
35–85% B (114–119 min); Gradient 2 (increase over 135
mins) 1% B (0–24 min), 1–5% B (24–25 min), 5–32% B (25–
144 min), 32–35% B (144–154 min), 35–85% B (154–
159 min). Peptides were sprayed directly into a hybrid linear
ion trap – Orbitrap mass spectrometer (LTQ-Orbitrap Velos)
and analyzed using a “high/high” acquisition strategy, detecting
peptides and at high resolution in the Orbitrap and analyzing
fragmentation products also in the Orbitrap. Precursor scan
(MS) spectra were acquired in the data-dependent mode,
detecting in the Orbitrap at 100 000 resolution. The eight most
intense triply charged or higher precursors for each acquisition
cycle, were isolated with a 2 Th m/z window and fragmented
in the ion trap with collision-induced dissociation (CID) at a
normalized collision energy of 35. Subsequent product (MS2)
fragmentation spectra were then recorded in the Orbitrap at
7500 resolution. A dynamic exclusion window (with single
repeat count) of 60 s was applied and automatic gain control
targets were set to 1x 106 (precursor scan) and 1  105
(product scan). Raw files for crosslinking searches were
processed using MaxQuant software (v. 1.2.2.5) using default
parameters, except for the setting “Top MS/MS peaks per
100 Da”, which was set to 100. Peak lists were searched
against the sequence of aSyn using Xi software (v. 1.7.5.1).
The following search parameters were applied: MS accuracy,
6 ppm; MS/MS accuracy, 20 ppm; missing mono-isotopic
peaks, 2; variable modifications, carbamidomethylation (Cys)
and oxidation (Met); enzyme, V8, with a maximum of four
missed cleavages allowed; crosslinker modification mass (Tyr-
Tyr), 2.015650 Da. Matched crosslinks were mapped to the
primary protein structure using xiNET.RCSN3 cell lysates, DEPC treatment and H2O2
quantification
RCSN3 cells (rat cortical substantia nigra neurons) were grown
in DMEM HAM F12 medium (PAA) supplemented with 12.5%
fetal calf serum (FCS) and 1% penicillin/streptomycin to
confluency in 175 cm2 flasks, in a 5% CO2 humidified
environment at 37 C. Following medium removal and washing
with PBS, 100 lL of chemical lysis buffer (50 mM Tris-HCl pH
7.4, 0.1% Triton X, 0.25% Na-deoxycholate, 150 mM NaCl,
1 mM NaF, no reducing agents) was added to each flask.
Cells were detached with a plastic scraper and collected
lysates were centrifuged at 16,000g for 30 min. Total protein
concentrations of soluble fractions were determined with a
Bradford assay (BioRad) and adjusted to 3 mg/mL with NMR
buffer. For inactivation with DEPC (Sigma) concentrated stock
solutions were prepared in 100% ethanol. DEPC was added to
RCSN3 lysates to final concentrations of 50 mM and
incubated for 22 h at 25 C. aSyn (50 lM) and cyt c (50 lM)
were mixed with native and DEPC-inactivated RCSN3 lysate
aliquots and 0.5, 10, 50 and 500 mM of H2O2 (input
concentrations). To determine amounts of remaining H2O2 in
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detection kit was employed (AssayDesigns, Stressgen).
Small unilamellar vesicles (SUVs)
SUVs were prepared from commercial pig-brain polar lipid
extract (Avanti) as reported in Theillet et al.37 The lipid powder
was dissolved in NMR buffer at a concentration of 16 mg/mL
(aprox. 20 mM assuming an average lipid mass of 800 Da) and
vortexed at room temperature for 30min. The solution was frozen
and thawed 5 times on dry-ice and a 37 C water-bath, sonicated
for 20 min at 4 C using 30% sonicator output power (Brandelin
Sonoplus) and centrifuged at 16,800g for 10 min to remove rem-
nant insoluble material. The resulting average vesicle size was
60 nm as determined by DLS. For the binding experiments we
added 50 lM of 15N-isotopically enriched aSyn or HMWA to
SUV solutions (final concentration ~16 mM after aSyn or HMWA
addition). NMR spectra were recorded at 30 C.
Thioflavin T (ThT) aggregation assay
Kinetic aggregation assays were performed with 100 lL aliquots
of 50 lM monomeric aSyn (in 100 mM Na-phosphate, 10 mM
NaCl, pH 7.2), or monomeric aSyn in the presence of 5 lM
HMWAs (10%), and 20 lM Thioflavin T (ThT) in low-binding
96-well plates (Corning), shaken at 200 rpm with one 2 mm
glass bead per well, at 37 C. Samples were shaken
continuously for 2 h before ThT fluorescence emission was
recorded at 485 nm (excitation at 440 nm) on a plate reader
(InfinitE M200). Samples were set up in triplicates. Data points
in Figure 4(d) correspond to the mean value, error bars denote
standard errors of the mean (SEM).
MTT metabolic assay
PC12 (rat pheochromocytoma, American Type Culture
Collection) cells were cultured in DMEM medium (Gibco BRL)
supplemented with 5% FBS, 10% horse serum and 3 mM
glutamine. Cells were plated at a density of 103 cells per well
in 96-well plates coated with polylysine in 90 lL of fresh
medium in a 5% CO2 humidified environment at 37 C. After
24 h, aliquots of aSyn protofibrils, pure HMWAs or aSyn-
HMWA aggregation mixtures were added at concentrations of
0.03, 0.06, 0.13, 0.25, 0.5 and 1 lM, in three replicates. Cells
were incubated for 3 days at 37 C. Cytotoxicity was
measured using an MTT assay kit (Promega) by determining
Formazan absorbance at 590 nm on a Tecan Safire
automated plate reader. Absorbance values obtained from
samples containing aggregated or fibrillar species and from
untreated cells were averaged and used to calculate cell
viability. Viability was expressed in percentage compared to
untreated cells (100%). Error bars indicate SEM values.
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